By Rishika Sadam and Kashish Tandon Jan 23 (Reuters) - Indian drugmakers Sun Pharmaceutical Industries, Zydus Lifesciences ...
Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...
Indian drugmaker Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Novo Nordisk A/S’s Ozempic in March ...
The post “A Godsend”: ProPublica’s Rx Inspector Tool Is Helping People Find Critical Safety Information on Generic Drugs ...
The post ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs appeared first on ProPublica.
British Columbians could soon have access to cheaper versions of injectable diabetes and obesity drugs.
The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for treatment of bovine respiratory disease and control of associated fever in beef and nonlactating dairy cattle.
A federal court in Pennsylvania granted final approval of a $200 million class-action settlement resolving antitrust claims that generic drug manufacturers conspired to inflate prices. The agreement ...
We’ve launched a first-of-its-kind app to help you find out where your generic drugs come from and see the track records of ...
Every week through October, we are examining the medical, business and cultural systems that contribute to the dichotomy that is the American health care system — a system that benefits some but costs ...
The ​Association for Accessible Medicines, which represents generic drugmakers, is expanding its roster of hired guns.